Michael Böhm

Research interests

Publications

• 2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  European Journal of Heart Failure · 2024 · 10.1002/ejhf.3024

• 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

  European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae179

• 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad195

• 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  European Journal of Heart Failure · 2022 · https://doi.org/10.1002/ejhf.2333

• Cardiovascular Disease in Chronic Kidney Disease

  Circulation · 2021 · https://doi.org/10.1161/circulationaha.120.050686

• Empagliflozin in Heart Failure with a Preserved Ejection Fraction

  New England Journal of Medicine · 2021 · 10.1056/nejmoa2107038

• Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

  European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2115

• Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

  European Heart Journal · 2021 · 10.1093/eurheartj/ehab670

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190

• Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

  New England Journal of Medicine · 2020 · 10.1056/nejmoa2025797

• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1911303

• Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

  European Heart Journal · 2017 · 10.1093/eurheartj/ehx564

• Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

  European Heart Journal · 2016 · 10.1093/eurheartj/ehv727

• Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1406761

• Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

  Circulation · 2014 · 10.1161/circulationaha.114.013748

• 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)

  Journal of Hypertension · 2013 · 10.1097/hjh.0b013e328364ca4c

• Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial

  The Lancet · 2013 · 10.1016/s0140-6736(13)61783-3

• 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

  Blood Pressure · 2013 · 10.3109/08037051.2014.868629

• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs104

• Update on Myocarditis

  Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2011.09.074

• Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1208410

• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

  The Lancet · 2010 · 10.1016/s0140-6736(10)61198-1

• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

  The Lancet · 2010 · 10.1016/s0140-6736(10)61259-7

• ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

  European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.08.005

• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

  European Heart Journal · 2008 · 10.1093/eurheartj/ehn309

• Rosuvastatin in Older Patients with Systolic Heart Failure

  New England Journal of Medicine · 2007 · 10.1056/nejmoa0706201

• Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi115

• Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

  New England Journal of Medicine · 2005 · 10.1056/nejmoa043814

Current projects

No projects listed.